De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study-Reference-Cited by-同舟云学术

De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study

Published:2023-03-09 Issue:1 Volume:199 Page:81-89
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

van Hemert Annemiek K. E.^ORCID,van Olmen Josefien P.,Boersma Liesbeth J.,Maduro John H.,Russell Nicola S.,Tol Jolien,Engelhardt Ellen G.,Rutgers Emiel J. Th.,Vrancken Peeters Marie-Jeanne T. F. D.,van Duijnhoven Frederieke H.

Funder

KWF Kankerbestrijding

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-023-06899-y.pdf

Reference41 articles.

1. Murphy BL, Boughey JC (2018) ASO author reflections: changes in use of neoadjuvant chemotherapy over time-highest rates of use now in triple-negative and HER2+ disease. Ann Surg Oncol 25(Suppl 3):695–696. https://doi.org/10.1245/s10434-018-7046-9

2. Shin HC, Han W, Moon HG, Im SA, Moon WK, Park IA et al (2013) Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients. Ann Surg Oncol 20(8):2582–2589. https://doi.org/10.1245/s10434-013-2909-6

3. Mieog JS, van der Hage JA, van de Velde CJ (2007) Neoadjuvant chemotherapy for operable breast cancer. Br J Surg 94(10):1189–1200. https://doi.org/10.1002/bjs.5894

4. von Minckwitz G, Blohmer JU, Costa SD, Denkert C, Eidtmann H, Eiermann W et al (2013) Response-guided neoadjuvant chemotherapy for breast cancer. J Clin Oncol 31(29):3623–3630. https://doi.org/10.1200/JCO.2012.45.0940

5. von Minckwitz G, Eidtmann H, Rezai M, Fasching PA, Tesch H, Eggemann H et al (2012) Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer. N Engl J Med 366(4):299–309. https://doi.org/10.1056/NEJMoa1111065

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility of breast conserving surgery alone in HER2-positive exceptional responders to neoadjuvant systemic therapy;European Journal of Surgical Oncology;2024-12

2. Precision Oncology in Breast Cancer Surgery;Surgical Oncology Clinics of North America;2024-04

3. Locoregional Therapies for Treatment of Invasive Breast Cancer: Review of Contemporary Clinical Trials;Current Breast Cancer Reports;2024-02-12

4. The Role of Sentinel Lymph Node Biopsy in Breast Cancer Patients Who Become Clinically Node-Negative Following Neo-Adjuvant Chemotherapy: A Literature Review;Current Oncology;2023-09-25

5. Radiothérapie des cancers du sein : questions d’actualité en 2023;Cancer/Radiothérapie;2023-09